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Upper airway dryness is a frequent side-eect of nasal continuous positive airway pressure therapy (nCPAP) in
obstructive sleep apnoea (OSA). In this situation, heated or non-heated passover humidifiers are often added to the
nCPAP-therapy. The ecacy of these two modes in terms of increasing the absolute humidity of the inspired air in
vivo has so far not been established. The present investigation was therefore designed to compare various heated
and non-heated passover humidifiers in terms of the their ability to increase the absolute humidity in the inspired
air during nCPAP.
In six healthy test individuals, nCPAP-therapy at pressures of 5 mbar and 10 mbar was simulated, and the
relative humidity and temperature of the air within the tube at the junction between CPAP tube and mask were
measured. In each test person, measurements were carried out both with and without the two heated (HC 1001,
Fischer&Paykel Inc., New Zealand and HumidAire1, ResMed Ltd., Australia) and two non-heated (Oasis1 and
Humidifier1, both from Respironics Inc., U.S.A.) passover humidifiers under steady-state conditions. The absolute
humidity was calculated from the relative humidity and temperature measurements.
The mean (SD) absolute humidity (gm73) in the steady-state was significantly (P5005 higher with each of the
humidifiers than that calculated when no humidifier was used. The relevant figures were as follows: no humidifier:
102 (18) gm73 (at 5 mbar)/98 (18) gm73 (at 10 mbar); Humidifier1: 164 (097)/156 (126); Oasis1: 173 (097)/
167 (093); HC1001: 265 (140)/262 (123); HumidAire1: 318 (250)/309 (264). The mean increase in absolute
humidity (in gm73) with the aid of the heated humidifiers was 163 (5 mbar) gm73/164 (10 mbar) gm73 with
HC1001 and 216/211 with HumidAire1, and in both cases was clearly and significantly (P=0028) higher in
comparison with the non-heated humidifiers—62/58 with Humidifier1 and 72/69 with Oasis1.
In terms of the absolute humidity achieved within the CPAP tube system, the heated humidifiers were clearly
superior to the non-heated humidifiers. These results were, however, obtained under laboratory conditions, and
therefore cannot be translated unreservedly to the situation represented by long-term CPAP-treatment.
Furthermore, it is possible that the smaller humidification capacity of the non-heated humidifiers may still suce
to meet the requirements of clinical use in terms of eectively preventing dry airways under CPAP treatment. This
point, however, needs further investigation on the basis of long-term clinical studies.
Key words: continuous positive airway pressure; sleep apnoea-syndrome; heated humidification; non-heated
humidification; dry upper airways.
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Obstructive sleep apnoea syndrome (OSA) occurs in about
4% of middle aged-men and 2% of middle-aged women (1).
Nasal continuous positive airway pressure therapyReceived 14 April 1999 and accepted in revised form 26 October
1999.
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0954-6111/00/040364+05 $35?00/0(nCPAP) is the treatment of choice for this condition (2).
Numerous studies have demonstrated the ecacy of
nCPAP reducing symptoms (e.g. daytime sleepiness),
improving long-term survival, and preventing such sequelae
as cardiovascular complications of OSA (3,4,5,6). However,
nCPAP is associated with a high frequency of troublesome
side eects, such as dryness of the nose, mouth and throat,
sneezing, nasal drip, nasal congestion, sinusitis, air swal-
lowing, nose bleeding, adverse eects associated with the
nasal mask, conjunctivitis due to air leaking from mask, etc.
(7).
Among the most frequently reported side eects is
dryness of the nose, mouth and throat, which is experienced# 2000 HARCOURT PUBLISHERS LTD
HEATED AND NON-HEATED HUMIDIFIERS DURING NCPAP-THERAPY 365by 30–66% of patients on nCPAP (5,7,8,9,10). To deal with
this problem, most authors recommend the use of a heated
or non-heated passover humidifier integrated in the tube
connecting the nCPAP-device and the nasal mask
(5,11,12,13). Both heated and non-heated passover humi-
dification are now being used all over the world by an
increasing number of patients with nCPAP-related upper
airway dryness.
Heated passover humidification has been shown to be
highly eective in the treatment of upper airway dryness
under nCPAP (13). The cheaper alternative non-heated
passover humidification might also suce to provide
eective relief of nCPAP-related upper airway dryness,
but has not yet been evaluated in clinical trials and further
investigations are needed. However, before initiating such
trials involving large groups of patients, the ecacy of
heated and non-heated passover humidification in terms of
moistening the inspired air within the CPAP tube system
should be investigated. Moreover, the question also arises
as to whether dierent passover humidifiers with the same
principle of humidification (e.g. dierent heated humidi-
fiers) achieve similar results.
The present investigation was therefore designed to
enable a comparison between various heated (HC1001,
Fischer&Paykel Inc, New Zealand and HumidAire1,
ResMed Ltd, Australia) and non-heated (Oasis1 and
Humidifier1, both from Respironics Inc, U.S.A.) passover
humidifiers with regard to their ability to increase the
absolute humidity of the inspired air during nCPAP.
Materials and methods
The investigations were performed on six healthy, male test
individuals (mean age 303+31 years, body mass index
255+33 kgm72) with no history of upper airway disease.
During the 24 h prior to the investigations, the test
individuals did not partake of either nicotine or alcohol.
At least 24 h before the start of the investigations, the test
individuals underwent nCPAP treatment at pressures of 5
and 10mbar, each applied for 1 h, to accustom them to
breathing under nCPAP conditions.
The test individuals were placed in a supine position on a
flat examination table and were connected, via a nasal mask
(Flow Plus1 Devillbis Inc., Pennsylvania, U.S.A.), to a
conventional constant pressure CPAP device (Somnotron
III1 Weinmann, Inc., Germany, the most commonly
employed CPAP-device in Germany). In this type of CPAP
device, an electronically controlled turbine is used to
generate a continuous elevated pressure in the tube system.
The pressure fluctuations within the tube system between
inspiration and expiration are less than 03 mbar. The Flow
Plus1 is a silicone mask provided with two air-exit
openings in the lower half, of the type usually and
frequently used for nCPAP treatment. The dimensions of
the air-exit openings correspond to those usual in CPAP
therapy (14). All measurements were carried out with the
test individuals in the wake state and breathing quietly. Via
a short adapter located between the mask and CPAP tube,
the sensors of a calibrated thermometer (Humitter1,Vaisala, Inc., Germany) and a calibrated hygrometer
(Intercap1, Vaisala, Inc., Germany) were introduced into
the tube system, with the aid of which the temperature and
relative humidity within the tube system were measured
continuously. The CPAP pressure applied was measured
continuously at the mask (RT-Pak1, Jaeger and Toennies,
Inc., Germany). The data thus obtained were fed into a
computer-aided polygraph (SleepLab1, Jaeger and Toen-
nies, Inc., Germany) and recorded.
CPAP pressures of 5 and 10 mbar, the temperature and
relative humidity within the CPAP tube system were
measured, in each case until a steady-state was achieved,
first without a humidifier and then for each of the
humidifiers in sequence. These humidifiers were the non-
heated passover humidifiers Humidifier1 and Oasis1 (both
from Respironics Inc., Murreysville, Pennsylvania, U.S.A.)
and the two heated passover humidifiers HC1001
(Fischer&Paykel Inc., Auckland, New Zealand) and
HumidAire1 (ResMed Ltd., North Ryde, Australia). Both
the Humidifier1 and the Oasis1 are conventional cold
passover humidity generators, in which the air passes into
the water reservoir (humidification chamber) and picks up
water vapour by free evaporation. The HC1001 and the
HumidAire1 are heated passover humidity generators.
Here, in contrast to the cold passover humidifiers, the
temperature of the water in the humidification chamber is
raised so as to increase the water vapour production. By
increasing the water temperature, extra energy is added to
the individual molecules, allowing more of them to escape
from the liquid phase. This increases the rate at which water
vapour is generated and made available to the airstream.
The humidifiers were connected to the tube of the CPAP
device in accordance with the manufacturers’ recommenda-
tions. The settings to the humidifiers and the filling of the
humidification chamber with boiled tap water were also as
recommended. In both heated humidifiers, the water in the
humidification chamber was heated on a hot plate, the
temperature of which can be regulated in steps. For the
investigations, the highest setting was selected in each case.
So as not to unnecessarily delay achievement of the steady-
state and of the exchange of one humidifier for the next, all
humidifiers were filled with water and (where applicable)
preheated in a separate room prior to the start of the
investigations. The humidifiers remained in the separate
room until just before they were needed.
During the application, temperature and relative humid-
ity were measured continuously in the examination room.
For this purpose, a thermometer and hygrometer, as used
for the measurements in the CPAP system, were used. All
recordings were carried out in a side room, in which the test
persons were continuously monitored via a video camera
for the duration of the investigations.
DATA EVALUATION AND STATISTICAL
ANALYSIS
The absolute humidity was calculated from the
relative humidity and temperature using the following
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HA  HR
T
 PS MH2O
R
HA=absolute humidity (gm
73); HR=relative humidity
(%); T=temperature (Kelvin); PS=saturated vapour pres-
sure (Nm72) at temperature TMH20=Molar mass of water
(18gmol71); R=Gas constant (138054610723 Nm/
K660225361023 mol).
All figures are expressed as arithmetic means+standard
deviations (SD) and range in brackets. Group comparisons
were performed using the Wilcoxon test for matched-
pairs. The statistical calculations were performed using
SPSS (version 6.0.1). For dierences between groups a
two-tailed P-value of less than 005 was considered
significant.TABLE 1. Characteristics of test persons (n=6)
Male/female 6/0
Age (years) 303 (31)
[26–35]
BMI* (kgm72) 255 (33)
[228–32]
FEV1 (litre) 447 (02)
[415–476]
FEV1% predicted 1008 (34)
[799–107]
Values are means (SD), ranges in brackets. BMI: body mass
index=weight height72 (kgm72); FEV1: forced expiratory
volume in 1 sec (l); FEV1% predicted: forced expiratory
volume in 1 sec percentage of predicted value.
TABLE 2. Temperature, relative and absolute humidity (steady s
Without
humidifier
Non-heated
Humidifier1
Temp. (8C) 255 (065) 244 (080)8
(5 mbar) [244–264] [231–254]
Temp. (8C) 263 (065) 242 (066)*
(10 mbar) [255–275] [234–251]
Rel. hum. (%) 437 (668) 744 (221)*
(5 mbar) [360–521] [709–765]
Rel. hum. (%) 401 (622) 714 (332)*
(10 mbar) [329–478] [669–743]
Abs. hum. (g/m3) 102 (180) 164 (097)*
(5 mbar) [78–126] [150–174]
Abs. hum. (g/m3) 98 (180) 156 (126)*
(10 mbar) [76–123] [137–168]
Values are means (SD) with range in brackets, Temp.: temperat
hum.: absolute humidity (gm73); 5 mbar: CPAP-pressure 5 mba
value without humidifier (P5 005), 8 significantly lower than vResults
TEST INDIVIDUALS AND CONDITIONS IN
THE TEST ROOM
The test individual characteristics are summarized in
Table 1. In all six test individuals the investigations were
carried out in accordance with the protocol.
The temperature of the investigation room during all the
measurements was between 259 and 2698C, the relative
humidity between 361 and 447% and the absolute
humidity between 88 and 115 g/m3. Systematic variations
were not recorded. The maximum variation within the
individual test series in a single person was 038C for room
temperature, 17 % for relative humidity and 05 gm73 for
absolute humidity.
TEMPERATURE, RELATIVE AND
ABSOLUTE HUMIDITY IN THE CPAP TUBE
SYSTEM
The mean temperature, mean relative and mean absolute
humidity at steady-state for all measurements are shown in
Table 2. The mean steady-state relative and absolute
humidities were significantly (P5005) higher with each
of the humidifiers as compared with non-use of a
humidifier. The mean steady-state temperature was sig-
nificantly higher for each of the two heated humidifiers, and
significantly lower for each of the non-heated humidifiers in
comparison with the figures obtained without the use of a
humidifier (P5005). Humidification performance, that is,
the increase in absolute humidity, of the two heated
humidifiers was more than twice as high as that of the
two non-heated humidifiers (see Figs 1 and 2).tate)
humidifiers Heated humidifier
Oasis1 HC 1001 Humid Aire1
243 (073)8 276 (083)* 311 (146)*
[230–251] [263–286] [295–328]
241 (087)* 273 (072)* 306 (148)*
[225–251] [261–281] [292–325]
787 (124)* 100 (0,0)* 100 (004)*
[777–805] [100–100] [999–100]
761 (184)* 999 (020)* 100 (00)*
[731–785] [995–100] [100–100]
173 (097)* 265 (140)* 318 (250)*
[162–187] [245–279] [293–350]
167 (093)* 262 (123)* 309 (264)*
[155–183] [244–276] [285–347]
ure (degree 8C); Rel. hum.: relative humidity (percent); Abs.
r, 10 mbar CPAP-pressure 10 mbar,*significantly higher than
alue without humidifier (P5005).
FIG. 1. Mean increase in the absolute humidity during
CPAP at 5 mbar.
FIG. 2. Mean increase in the absolute humidity during
CPAP at 10 mbar.
HEATED AND NON-HEATED HUMIDIFIERS DURING NCPAP-THERAPY 367Also, the humidification performance of the two heated
humidifiers diered appreciably. In the case of Humid
Aire1, for example, the increase in absolute humidity at
both pressures was approximately 30% higher than in the
case of the HC1001. The dierence between the two non-
heated humidifiers was markedly less. The increase in
absolute humidity for the Oasis1 was roughly 20 % higher
than that seen with the Humidifier1 (see Figs 1 and 2).
Discussion
Upper airway dryness is a common and troublesome side
eect of nCPAP therapy for OSA (5,7,8,10,11). In this
situation most authors recommend the use of a non-heated
passover humidifier or a heated passover humidifier
integrated within the tube connecting the nCPAP device
and the nasal mask (5,7,11,13). Both non-heated passover
humidifiers and the often more expensive heated passover
humidifiers are now being used by an increasing number of
patients with nCPAP-related upper airway dryness
throughout the world.
Comparative studies on the therapeutic ecacy of the
two methods in continuous operation have so far not been
performed. Nor is it known whether devices using the same
humidification principle, but produced by dierent compa-nies dier in terms of therapeutic eectiveness. Our
investigations have been performed with the aim of
determining—initially under controlled conditions in the
laboratory—the extent to which various devices are
technically capable of increasing absolute humidity of the
inspired air within the tube in vivo under nCPAP conditions
and to compare the humidification performances.
The values measured within the CPAP tube system are
influenced by the temperature and the relative and absolute
humidities in the examination room. For this reason, these
parameters were recorded continuously during the investi-
gations. The recordings revealed no trends and only slight
fluctuations of up to 5% within the individual test series. A
significant influence on the results is therefore not to be
expected.
Generally speaking, the absolute humidity within the
tubing was clearly increased by all the humidifiers tested.
The heated humidifiers were much superior to the non-
heated humidifiers in terms of increasing the absolute
humidity of the inspired air. This result is easily explained
by the fact that hot air can carry a higher maximum
absolute humidity than cold air—a well known phenom-
enon observed by many authors (12,13,17).
In this connection it should be noted that for our
investigations the hot plate was set to the highest
temperature, so that we measured the maximum perfor-
mance of the heated humidifiers. In the practical, dom-
iciliary setting, however, at low room temperatures, in
particular in winter, condensation in the tube (17) might
oblige the patient to reduce the temperature of the hot
plate. Under these conditions, the benefits of the heated
humidifier would then be diminished.
At a pressure of 10 mbar, the mean temperature and
relative and absolute humidities were slightly lower than at
5 mbar for all the humidifiers tested. It may be supposed
that this observation is due to a greater loss of humid, warm
air through the air-exit openings in the mask, and a reduced
return flow of respired air into the CPAP tube under the
higher pressure. As a function of CPAP pressure, the
humidification performance of the devices investigated—at
least within the pressure spectrum commonly employed in
the treatment of OSA—appears to fluctuate only slightly,
and has probably no significant influence on clinical
eectiveness. Using the non-heated humidifiers, the tem-
perature in the tube system was lower than when no
humidifier was used. The probable reason for the decrease
in temperature is that the energy expended during conver-
sion of water molecules in the humidification chamber from
the liquid to the gas form (heat of evaporation) is, at least in
part, lost to the tube system. Whether this slight cooling
eect on the air temperature might influence therapeutic
‘comfort’ cannot be definitively assessed here. It does,
however, appear conceivable that some patients who
already complain of a cooling of the upper airways during
CPAP therapy will be unlikely to benefit from such a non-
heated humidifier.
In terms of the absolute humidity of the inspired air,
small but significant dierences in humidification perfor-
mance were found between the two humidifiers of the same
humidification principle, heated and non-heated. This
368 G. H. WIEST ET AL.means that the results obtained with one humidifier
must not be translated uncritically to other commer-
cially available humidifiers of the same humidification
principle.
If our results are applied to the situation of permanent
domiciliary treatment, it must be remembered that in this
setting a number of factors—optimized or of no relevance
under laboratory conditions—may influence the humidifi-
cation eect. Thus, for example, incorrect operation or
servicing of the machine may have a negative influence,
while simple, patient-friendly operation of the humidifier
may have a positive influence.
In view of all this, further studies are needed to
investigate the functionability and clinical ecacy of
various humidifiers in the long-term domiciliary use setting.
Some authors consider nocturnal leakage of air at the
mouth during CPAP treatment to be a common cause of
drying of the upper airways (15,16). Although we did not
simulate this specific situation, it may be assumed that
the leakage of large amounts of humid, warm air would
place particular demands on the performance of the
humidifier. In just such a situation, the results of our
investigation suggest the need for an ecient heated
humidifier.
In summary, with the aid of the heated passover
humidifiers investigated, a considerably higher increase in
the absolute humidity of the inspired air was achieved than
was possible with non-heated passover humidifiers. How-
ever, with the latter, too, the absolute humidity in the
CPAP tube system increased appreciably. A prospective
clinical study showed a high level of ecacy for a heated
passover humidifier in the treatment of dry airways
occurring under CPAP treatment (13). To date, no such
studies have been carried out for non-heated passover
humidifiers. It is, however, possible that the smaller
humidification capacity of the considerably cheaper non-
heated passover humidifiers may still suce in clinical use
to eectively prevent dry airways under CPAP treatment.
This question, however, needs further investigation in
clinical long-term studies.
In the meantime, it would appear justified, despite the
higher costs, to employ the appreciably more expensive
heated passover humidifiers to prevent dry upper airways
under CPAP therapy.
References
1. Young T, Palta M, Dempsey J, Skatrud J, Weber S,
Badr S. The occurrence of sleep-disordered breathing
among middle-aged adults. N Engl J Med 1993; 328:
1230–1235.
2. Strollo PJ Jr, Rodgers RM. Obstructive sleep apnea. N
Engl J Med 1996; 334: 99–104.3. Partinen M, Gilleminault C. Daytime Sleepiness and
Vascular Morbidity at Seven-Year Follow-up in
Obstructive Sleep Apnea Patients. Chest 1990; 97:
27–32.
4. Hudgel DW. Treatment of Obstructive Sleep Apnea. A
Review. Chest 1996; 109: 1346–1358.
5. Grunstein RR. Sleep related breathing disorders. 5.
Nasal continuous positive airway pressure treatment
for obstructive sleep apnoea. Thorax 1995; 50:
1106–1113.
6. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ.
Daytime sleepiness, cognitive performance and mood
after continuous positive airway pressure for the sleep
apnoea/hypopnoea syndrome. Thorax 1993; 48:
911–914.
7. Pepin JL, Leger P, Veal D, Langevin B, Robert D,
Levy P. Side Eects of Nasal Continuous Positive
Airway Pressure in Sleep Apnea Syndrome. Chest 1995;
107: 375–381.
8. Engleman HM, Martin SE, Douglas NJ. Compliance
with CPAP therapy in patients with the sleep apnoea/
hypopnoea syndrome. Thorax 1994; 49: 263–266.
9. Rauscher H, Formanek D, Popp W, Zwick H. Self-
Reported vs Measured Compliance with Nasal CPAP
for Obstructive Sleep Apnea. Chest 1993; 103: 1675–
1680.
10. Sanders M, Gruendl C, Rodgers R. Patient Compli-
ance with Nasal CPAP Therapy for Sleep Apnoea.
Chest 1986; 90: 330–333.
11. Wiest GH, Ficker JH, Mu¨ller A, Hahn EG. Neben-
wirkungen der CPAP-Therapie beim obstruktiven
Schlafapnoesyndrom. Ursachen und Therapie.
Atemw-Lungenkrkh 1998; 24: 95–102.
12. Fleury B, Barros Vieira S, Rakotonanahary D,
Gagnadoux F, Hausser-Hauw C, Lebeau B. Compar-
ison of cold passover versus heated humidification
during nCPAP therapy. Am J Respir Crit Care Med
1997; 155: A304.
13. Wiest GH, Lehnert G, Bru¨ckl WM, Meyer M, Hahn
EG, Ficker JH. A heated humidifier reduces upper
airway dryness during continuous positive airway
pressure therapy. Respir Med 1999, 93: 21–26.
14. Raschke F, Fischer J. Dynamik von Druck und
Flußkurven verschiedener Auslaßventile. Med Klin
1997, 92: 82–84.
15. Richards GN, Cistulli PA, Ungar RG, Berthon-Jones
M, Sullivan CE. Mouth Leak With Nasal Continuous
Positive Airway Pressure Increases Nasal Airway
Resistance. Am J Respir Crit Care Med 1996, 154:
182–186.
16. Hayes MJ, McGregor FB, Roberts DN, Schroter RC,
Pride NB. Continuous nasal positive airway pressure
with a mouth leak: eect on nasal mucosal blood flux
and nasal geometry. Thorax 1995, 50: 1179–1182.
17. Peterson BD. Heated humidifiers. Structure and func-
tion. Respir Care Clin N Am 1998, 4: 243–259.
